A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers ...
Nov 18, 2022
0
951
Researchers in the College of Agriculture, Health and Natural Resources are working to unlock a decades-long mystery that has hampered development of a walking pneumonia vaccine.
Nov 9, 2022
0
35
Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill ...
Oct 27, 2022
0
43
Knowing how well vaccination against one SARS-Co-V2 strain (with or without previous infection) counteracts infection with a different strain is a critical research question. The answers could guide strategies to continue ...
Oct 24, 2022
0
56
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic joint inflammation that leads to functional impairment in many sufferers. There are gender-specific differences in the emergence and development ...
Oct 21, 2022
0
43
B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are "programmed" during development is key to ...
Oct 12, 2022
0
92
A new discovery about how cells make antibodies has revealed the surprisingly random way the body's immune system defends against infection and disease.
Oct 4, 2022
0
56
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
Between 10 and 20 million people worldwide are infected with hepatitis D virus (HDV). HDV infection is always associated with hepatitis B virus infection. So far there has been no satisfactory therapeutic option for this ...
Oct 3, 2022
0
49
Researchers at La Jolla Institute for Immunology (LJI) have discovered how the immune system can transform into an antibody-making machine capable of neutralizing one of the most elusive viruses out there: HIV.
Sep 21, 2022
0
88
